| 发明名称 |
TREATMENT OF CIRCADIAN RHYTHM DISORDERS |
| 摘要 |
Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm. |
| 申请公布号 |
US2017100366(A1) |
申请公布日期 |
2017.04.13 |
| 申请号 |
US201615382526 |
申请日期 |
2016.12.16 |
| 申请人 |
Vanda Pharmaceuticals, Inc. |
发明人 |
Dressman Marlene Michelle;Feeney John Joseph;Licamele Louis William;Polymeropoulos Mihael H. |
| 分类号 |
A61K31/343;A61K9/00 |
主分类号 |
A61K31/343 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of entraining a patient suffering from Non-24 to a 24 hour sleep-wake cycle in which the patient awakens at or near a target wake time following a daily sleep period of approximately 7 to 9 hours, and maintaining said 24 hour sleep-wake cycle, said method comprising: treating the patient by orally administering to the patient 20 mg of tasimelteon once daily before a target bedtime. |
| 地址 |
Washington DC US |
